A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result
Brain Res (2011) 1421:11020 10.1016/j.brainres.2011.09.016 [DOI] [PubMed] [Google Scholar] 68.Albiston AL, Allen AM, Mendelsohn FA, Ping SE, Barrett GL, Murphy M, et al
Longhin E
No one should have to choose between their health and their wallet
Its a method that delivers essential nutrients directly into the bloodstream for immediate benefits
When Wegovy gained Food and Drug Administration approval for weight loss in 2021 as a weekly injectable, prescriptions soared, reaching nearly 121,000 scripts in 2023, the study said